FDA Important Updates from the Alabama Board of Pharmacy on Facility Applications and Renewals | by: Sumeet Singh, Founder & Chairman | Article Posted: October 26, 2023 | The Alabama Board of Pharmacy has recently made an announcement that affects companies...
It’s a matter of time until drone delivery of prescription drugs becomes the norm.
Amazon’s PillPack is fighting battles everyday, as it tries to wrest revenue, profit and valuation from deeply entrenched players in this (mostly) zero-sum game. However, as with everything else: you win some and you lose some. Below is a recount on some of the recent moves over the summer!
High reimbursement drug products have been an underground current in the practice of pharmacy for over a decade. However, only in the past 5 or 10 years has this part of the industry expanded enough to bring Federal attention.
Consolidation of purchase power in the past 20 years has dramatically changed the landscape for generic manufacturers; and recent events are making it worse: active prosecution for price-fixing, the FDA recently announcing a wave of unannounced FDA audits, and blame for the Opioid Epidemic. So what is a generic manufacturer to do? There are opportunities still available for a generic manufacturer to increase their top and bottom lines.
Drug Importation has been a longtime coming. The law that developed a framework for importation of prescription drugs originally became effective in January 2012 but over 7 years later, not much has been done. In September 2018, Vermont passed a bill SB175 (read our article on it here) which had specific challenges: DSCSA compliance, Diversion, Manufacturer tactics, Politics, Quality concerns, Relabeling costs, just to name a few.
10 Key Takeaways from the 2019 Controlled Substances Summit ACI Controlled Substances Summit 1. Suspicious Order Monitoring ("SOM") Systems: DEA...
